1. Home
  2. SNY
  3. SNY News

Latest Sanofi ADS (SNY) News on November 18, 2025

How to Get Workers Back to the Office? Fresh Air, Bees, and Farmers Markets.
SNY

Barrons.com

3 days ago

How to Get Workers Back to the Office? Fresh Air, Bees, and Farmers Markets.

Press Release: Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes
SNY

GlobeNewswire

4 days ago

Press Release: Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes

Sanofi (ENXTPA:SAN) Is Up 5.7% After Dupixent’s Positive Phase 3 Results in AFRS—What's Changed
SNY

Simply Wall St.

5 days ago

Sanofi (ENXTPA:SAN) Is Up 5.7% After Dupixent’s Positive Phase 3 Results in AFRS—What's Changed

Sanofi: Information concerning the total number of voting rights and shares – October 2025
SNY

GlobeNewswire

5 days ago

Sanofi: Information concerning the total number of voting rights and shares – October 2025

Why Analysts Are Rethinking Sanofi’s Outlook as Its Growth Narrative Evolves
SNY

Simply Wall St.

7 days ago

Why Analysts Are Rethinking Sanofi’s Outlook as Its Growth Narrative Evolves

Sanofi (ENXTPA:SAN): Exploring Whether Shares Trade Below Their True Value
SNY

Simply Wall St.

8 days ago

Sanofi (ENXTPA:SAN): Exploring Whether Shares Trade Below Their True Value

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%
SNY

Investor's Business Daily

10 days ago

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%

Novavax Q3 Earnings & Revenues Beat Estimates, '25 Sales View Raised
SNY

Zacks

11 days ago

Novavax Q3 Earnings & Revenues Beat Estimates, '25 Sales View Raised

SNY

MT Newswires

11 days ago

Regeneron, Sanofi Say Dupixent for Allergic Fungal Rhinosinusitis Met Primary Endpoint in Phase 3 Study

Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review
SNY

GlobeNewswire

11 days ago

Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review

Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review
SNY

GlobeNewswire

11 days ago

Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review

Novavax Inc (NVAX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial Challenges
SNY

GuruFocus.com

11 days ago

Novavax Inc (NVAX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial Challenges

SNY

Investing.com

12 days ago

Novavax beats revenue estimates, raises full-year guidance

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
SNY

PR Newswire

12 days ago

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Rezurock® now covered in Quebec for people living with chronic graft-versus-host disease (GVHD)
SNY

CNW Group

12 days ago

Rezurock® now covered in Quebec for people living with chronic graft-versus-host disease (GVHD)

A Look at Novavax's Valuation Following U.S. Vaccine Rights Transfer to Sanofi (NVAX)
SNY

Simply Wall St.

13 days ago

A Look at Novavax's Valuation Following U.S. Vaccine Rights Transfer to Sanofi (NVAX)

Examining Sanofi’s Valuation After Immunology Pipeline Expansion and New Strategic Partnership
SNY

Simply Wall St.

13 days ago

Examining Sanofi’s Valuation After Immunology Pipeline Expansion and New Strategic Partnership

CNS Summit releases annual Digital Innovation Index
SNY

PR Newswire

13 days ago

CNS Summit releases annual Digital Innovation Index

Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS
SNY

GlobeNewswire

13 days ago

Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS

Nucleic Acid Therapeutics Market Report 2025: Competition Intensifies as Pfizer, Sanofi, Novartis, Moderna, BioNTech Expand Antisense and RNA Platform Innovations - Long-term Forecast to 2029 & 2034
SNY

GlobeNewswire

13 days ago

Nucleic Acid Therapeutics Market Report 2025: Competition Intensifies as Pfizer, Sanofi, Novartis, Moderna, BioNTech Expand Antisense and RNA Platform Innovations - Long-term Forecast to 2029 & 2034

SNY

MT Newswires

14 days ago

Novavax Completes Nuvaxovid US Marketing Authorization Transfer to Sanofi

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment
SNY

PR Newswire

14 days ago

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Pulmonary Emphysema Market Set to Expand by 2034 with Rising COPD Prevalence and Therapeutic Innovation | DelveInsight
SNY

GlobeNewswire

15 days ago

Pulmonary Emphysema Market Set to Expand by 2034 with Rising COPD Prevalence and Therapeutic Innovation | DelveInsight

Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?
SNY

Zacks

15 days ago

Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?

Draig Therapeutics Appoints Seasoned Neuroscience Leader Ivana Magovčević-Liebisch as President and Chief Executive Officer
SNY

GlobeNewswire

15 days ago

Draig Therapeutics Appoints Seasoned Neuroscience Leader Ivana Magovčević-Liebisch as President and Chief Executive Officer

United States Multiple Myeloma Market Research Report 2025-2033, Profiles of Key Players - Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, Takeda, and Bristol-Myers Squibb
SNY

GlobeNewswire

15 days ago

United States Multiple Myeloma Market Research Report 2025-2033, Profiles of Key Players - Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, Takeda, and Bristol-Myers Squibb

Corporate venture firms stepped in for drug startups during biotech funding pullback
SNY

BioPharma Dive

18 days ago

Corporate venture firms stepped in for drug startups during biotech funding pullback

SNY

Morningstar Research

20 days ago

Analyst Report: Regeneron Pharmaceuticals, Inc.

Novavax (NVAX) Gains Momentum with Sanofi Deal and Analyst Endorsement
SNY

Insider Monkey

20 days ago

Novavax (NVAX) Gains Momentum with Sanofi Deal and Analyst Endorsement

BioMarin Beats on Q3 Earnings, Seeks to Divest Hemophilia Gene Therapy
SNY

Zacks

21 days ago

BioMarin Beats on Q3 Earnings, Seeks to Divest Hemophilia Gene Therapy

SNY

GlobeNewswire

21 days ago

Update: Dassault Systèmes: Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey

Looking at the Narrative for Sanofi After Recent Pipeline and Buyback Developments
SNY

Simply Wall St.

21 days ago

Looking at the Narrative for Sanofi After Recent Pipeline and Buyback Developments

SNY

MT Newswires

21 days ago

European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday

SNY

Argus Research

21 days ago

Market Digest: NLY, SNY, AVY, GE, WBD, TSLA, AGNC, BYND, NXPI

SNY

Argus Research

21 days ago

Analyst Report: Sanofi SA

SNY

Investing.com

21 days ago

Regeneron earnings beat estimates amid strong anti-inflammatory drug demand

Regeneron Reports Third Quarter 2025 Financial and Operating Results
SNY

GlobeNewswire

21 days ago

Regeneron Reports Third Quarter 2025 Financial and Operating Results

SNY

GlobeNewswire

21 days ago

Press release: Sanofi successfully prices USD 3 billion of bond issue

UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey
SNY

GlobeNewswire

21 days ago

UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update
SNY

PR Newswire

22 days ago

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update

SNY

Morningstar Research

24 days ago

Analyst Report: Sanofi

Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue
SNY

Investor's Business Daily

25 days ago

Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue

SNY

MT Newswires

25 days ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Sanofi SA (SNY) Q3 2025 Earnings Call Highlights: Strong Growth Driven by DUPIXENT and New Launches
SNY

GuruFocus.com

25 days ago

Sanofi SA (SNY) Q3 2025 Earnings Call Highlights: Strong Growth Driven by DUPIXENT and New Launches

SNY

MT Newswires

25 days ago

Sector Update: Health Care Stocks Advance Friday Afternoon

Sanofi (ENXTPA:SAN): Exploring Valuation Following Recent Share Price Momentum
SNY

Simply Wall St.

25 days ago

Sanofi (ENXTPA:SAN): Exploring Valuation Following Recent Share Price Momentum

Dupixent stirs Sanofi’s growth as vaccine sales cool
SNY

Pharmaceutical Technology

25 days ago

Dupixent stirs Sanofi’s growth as vaccine sales cool

SNY

MT Newswires

25 days ago

European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading

SNY

MT Newswires

25 days ago

Sector Update: Health Care Stocks Edge Higher Premarket Friday

SNY

MT Newswires

25 days ago

Sector Update: Health Care

Sanofi Jumps As Third-Quarter Dupixent Sales Near $5 Billion
SNY

Investor's Business Daily

25 days ago

Sanofi Jumps As Third-Quarter Dupixent Sales Near $5 Billion

SNY

MT Newswires

25 days ago

Earnings, Central Bank Outlook Damp European Bourses Midday

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

25 days ago

Health Care Roundup: Market Talk

SNY

MT Newswires

25 days ago

Sanofi Q3 Earnings, Sales Increase

Sanofi Earnings Get Boost From Dupixent, New Drugs as U.S. Talks Continue
SNY

The Wall Street Journal

25 days ago

Sanofi Earnings Get Boost From Dupixent, New Drugs as U.S. Talks Continue

SNY

Investing.com

25 days ago

Sanofi beats estimates on strong Dupixent sales, new drug launches; stock up

Earnings live: Tesla stock falls after earnings miss, American Airlines climbs, IBM and Hasbro sink
SNY

Yahoo Finance

a month ago

Earnings live: Tesla stock falls after earnings miss, American Airlines climbs, IBM and Hasbro sink

Electra Therapeutics secures $183m to fund Phase II/III trial of ELA026
SNY

Clinical Trials Arena

a month ago

Electra Therapeutics secures $183m to fund Phase II/III trial of ELA026

SNY

MT Newswires

a month ago

Sanofi Expands Partnership With Medidata to Deploy Artificial Intelligence in Life Sciences Research

RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER
SNY

GlobeNewswire

a month ago

RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER

Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey
SNY

GlobeNewswire

a month ago

Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey

SNY

GlobeNewswire

a month ago

Dassault Systèmes: Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey

SNY

Argus Research

a month ago

Market Update: TFC, DHR, KO, TXN, CLF

Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering
SNY

GlobeNewswire

a month ago

Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering

Earnings live: Netflix stock dives, AT&T, GE Vernova, and Hilton rise as Tesla earnings loom
SNY

Yahoo Finance

a month ago

Earnings live: Netflix stock dives, AT&T, GE Vernova, and Hilton rise as Tesla earnings loom

EQT Life Sciences Co-Leads USD 183 Million Series C Financing in Electra Therapeutics
SNY

PR Newswire

a month ago

EQT Life Sciences Co-Leads USD 183 Million Series C Financing in Electra Therapeutics

Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer
SNY

GlobeNewswire

a month ago

Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer

Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study
SNY

GlobeNewswire

a month ago

Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study

Emphysema Market Analysis Reveals Promising Growth Opportunities and Trends During the Forecast Period (2025-2034) | DelveInsight
SNY

PR Newswire

a month ago

Emphysema Market Analysis Reveals Promising Growth Opportunities and Trends During the Forecast Period (2025-2034) | DelveInsight

/C O R R E C T I O N -- Sanofi-Aventis Canada Inc./
SNY

CNW Group

a month ago

/C O R R E C T I O N -- Sanofi-Aventis Canada Inc./

Collaboration between operations and supply vital amid global shifts
SNY

Clinical Trials Arena

a month ago

Collaboration between operations and supply vital amid global shifts

SNY

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

Earnings live: Tesla, Netflix, General Motors, Ford, and P&G to headline third quarter earnings calendar this week
SNY

Yahoo Finance

a month ago

Earnings live: Tesla, Netflix, General Motors, Ford, and P&G to headline third quarter earnings calendar this week

Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors
SNY

GlobeNewswire

a month ago

Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors

Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose
SNY

GlobeNewswire

a month ago

Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose

Tesla, Netflix set to report earnings as US-China trade fight turns 'unsustainable': What to watch this week
SNY

Yahoo Finance

a month ago

Tesla, Netflix set to report earnings as US-China trade fight turns 'unsustainable': What to watch this week

SNY

MT Newswires

a month ago

Sanofi Says Europe Regulator Issues Negative Opinion on Chronic Graft-Versus-Host Disease Drug

SNY

MT Newswires

a month ago

Sanofi Says European Medicines Agency Recommends Wayrilz for EU Approval

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
SNY

GlobeNewswire

a month ago

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease
SNY

GlobeNewswire

a month ago

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease

I-Mab morphs into ‘hub-and-spoke’ biotech; Astellas passes on Taysha gene therapy
SNY

BioPharma Dive

a month ago

I-Mab morphs into ‘hub-and-spoke’ biotech; Astellas passes on Taysha gene therapy

SNY

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

Does Revvity’s (RVTY) Sanofi Partnership and Expanded T1D Diagnostics Shift Its Long-Term Growth Outlook?
SNY

Simply Wall St.

a month ago

Does Revvity’s (RVTY) Sanofi Partnership and Expanded T1D Diagnostics Shift Its Long-Term Growth Outlook?

SNY

MT Newswires

a month ago

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday on AI, Bank Strength

SNY

MT Newswires

a month ago

Sanofi, EVOQ Therapeutics Sign Collaboration, License Agreement

EVOQ Therapeutics Announces Collaboration and License Agreement with Sanofi
SNY

PR Newswire

a month ago

EVOQ Therapeutics Announces Collaboration and License Agreement with Sanofi

Sanofi Shares Rebound 6% as Investors Weigh New Valuation Amid Pipeline Progress
SNY

Simply Wall St.

a month ago

Sanofi Shares Rebound 6% as Investors Weigh New Valuation Amid Pipeline Progress

Top Novavax Shareholder Demands Company’s Sale
SNY

Barrons.com

a month ago

Top Novavax Shareholder Demands Company’s Sale

Sanofi: Information concerning the total number of voting rights and shares - September 2025
SNY

GlobeNewswire

a month ago

Sanofi: Information concerning the total number of voting rights and shares - September 2025

Nanomedicine Market Size to Reach US$ 389.52 Billion by 2033, Driven by Advancements in Targeted Therapies and Drug Delivery Innovations | According DataM Intelligence
SNY

PR Newswire

a month ago

Nanomedicine Market Size to Reach US$ 389.52 Billion by 2033, Driven by Advancements in Targeted Therapies and Drug Delivery Innovations | According DataM Intelligence

SNY

GlobeNewswire

a month ago

HMNC Brain Health Presents New Analysis Supporting Rationale for Combining a Genetic Patient Selection Tool with a Vasopressin V1b Receptor Antagonist in the Treatment of Depression at ISCTM Conference in Amsterdam

ITM Appoints Annette Breunig as Chief People Officer
SNY

GlobeNewswire

a month ago

ITM Appoints Annette Breunig as Chief People Officer

Global Protein Drugs Market to Reach $655.7 Billion by 2029
SNY

GlobeNewswire

a month ago

Global Protein Drugs Market to Reach $655.7 Billion by 2029

AstraZeneca ups investment in Virginia; Moderna vets launch VC fund
SNY

BioPharma Dive

a month ago

AstraZeneca ups investment in Virginia; Moderna vets launch VC fund

How Positive Phase II Results for AlphaMedix at Sanofi (ENXTPA:SAN) Have Changed Its Investment Story
SNY

Simply Wall St.

a month ago

How Positive Phase II Results for AlphaMedix at Sanofi (ENXTPA:SAN) Have Changed Its Investment Story

Why Apogee, A Rival To Regeneron And Sanofi, Rocketed 34% And Broke Out
SNY

Investor's Business Daily

a month ago

Why Apogee, A Rival To Regeneron And Sanofi, Rocketed 34% And Broke Out

RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes
SNY

Zacks

a month ago

RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes

Sanofi’s €320m bet pays off as radiopharmaceutical shows benefit in GEP-NETs
SNY

Clinical Trials Arena

a month ago

Sanofi’s €320m bet pays off as radiopharmaceutical shows benefit in GEP-NETs

SNY

MT Newswires

a month ago

BioVaxys Appoints James Tartaglia to Board

BenchSci Announces Three-Year License Agreement with Sanofi to Access and Use BenchSci’s ASCEND Platform
SNY

Business Wire

a month ago

BenchSci Announces Three-Year License Agreement with Sanofi to Access and Use BenchSci’s ASCEND Platform

Share on Social Networks: